On 09 March, HP Inc. (NYSE:HPQ) shares increased 2.81% and was closed at $11.36. HPQ EPS growth in last 5 year was -6.80%. HP Inc. (NYSE:HPQ) year to date (YTD) performance is -2.98%.
The HP Inc. (NYSE: HPQ) board of directors has declared a cash dividend of $0.124 per share on the company’s common stock. The dividend, the second in HP Inc.’s fiscal year 2016, is payable on April 6, 2016, to stockholders of record as of the close of business on March 9, 2016.
Rite Aid Corporation (NYSE:RAD) shares increased 0.25% in last trading session and ended the day at $8.02. RAD Gross Margin is 26.40% and its has a return on assets of 18.00%. Rite Aid Corporation (NYSE:RAD) quarterly performance is 1.13%.
On 3 March, Rite Aid Corporation (NYSE:RAD) announced sales results of its retail pharmacy segment for February. For the five weeks ended Feb. 27, 2016, same store sales decreased 0.8 percent over the prior-year period. February front-end same store sales decreased 0.5 percent. Pharmacy same store sales, which included an approximate 269 basis points negative impact from new generic introductions, decreased 0.9 percent. Prescription count at comparable stores increased 1.4 percent over the prior-year period.
Banco Bradesco S.A. (NYSE:BBD) caters to the Financial space. It has a net profit margin of 53.70% and weekly performance is 18.81%. On the last day of trading company shares ended up at $6.79. Banco Bradesco S.A. (NYSE:BBD) distance from 50-day simple moving average (SMA50) is 38.71%.
Banco Bradesco S.A. (NYSE:BBD) declared a monthly dividend. Investors of record on Friday, March 4th will be given a dividend of 0.004 per share on Friday, April 8th. This represents a $0.05 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date is Wednesday, March 2nd.
ITI Inc (NASDAQ:ITCI) shares moved down -5.60% in last trading session and ended the day at $27.82. ITCI has a return on assets of -50.00%. ITI Inc (NASDAQ:ITCI) quarterly performance is -46.52%.
On 4 March, ITI Inc (NASDAQ:ITCI) has teamed with endocon engineering, a Germany-based consulting firm specializing in product development and manufacturing processes as a value-added referral partner.
Amicus Therapeutics, Inc. (NASDAQ:FOLD) caters to the Healthcare space. Its weekly performance is -6.02%. On the last day of trading company shares ended up at $7.50. Amicus Therapeutics, Inc. (NASDAQ:FOLD) distance from 50-day simple moving average (SMA50) is -5.69%.
Janney Montgomery Scott upgraded shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) from a neutral rating to a buy rating in a research report published on Tuesday, The Fly reports. They currently have $12.00 price objective on the biopharmaceutical company’s stock, up from their prior price objective of $10.00.
Leave a Reply